diabetes header graphic


Avoiding Diabetes Complications
By Adrian Whittle
The numbers of people that have been diagnosed with in the past 20 years has increased to such an extent that many are describing the situation as an epidemic. This may be explained by people becoming more aware of the disease and thus diagnosing the condition more readily but the fact is that the disease is increasing at an unprecedented level. This increase is mainly in type 2 that is the result of insulin resistance. It is generally associated with older people and is often termed adult onset diabetes. Type 2 is generally the easier disease to manage and a person can lead a normal life, often without any form of medication, if they adhere to guidelines set by their doctor. It is important to follow the treatment guidelines given by your doctor or health care provider not just for your day to day life but for the long term complications that can result from diabetes. This article will cover the typical care regime for and the possible complications that can result if you do not follow these guidelines.

Treatment or care for type 2 comes down to four things. Eating the right food, getting proper and regular exercise, monitoring your blood sugar level and getting regular check ups. The sooner you adopt these potential changes in your lifestyle the less risk you may face of getting any diabetic complications.

When you are first diagnosed with diabetes, you will be educated on how the disease affects your body. Part of this education will be how to minimize this by eating the right foods. You will consult your doctor or a dietitian who will give you ideas on the types and quantities of food to eat. They will devise a meal plan

Could you have diabetic kidney disease and not even know it?
Questions to ask your doctor.

]]>

Diabetes is the leading cause of chronic kidney disease

Chronic kidney disease (CKD) is on the rise in part because diabetes is on the rise. If you are at risk for diabetes or have been recently diagnosed with the disease, here’s what you should know about the link between diabetes and CKD.

]]>

Diabetes and minorities: What are the risks?
Some ethnic groups develop diabetes at two to six times the rate of whites. If you are African American, Hispanic, Native American, Asian or Pacific Islander, here’s what you should know about your risk for diabetes.

]]>

Preventing chronic kidney disease when you have diabetes

Diabetes is the leading cause of chronic kidney disease. Keeping diabetes in check and early diagnosis of kidney disease could help decrease the chances of developing kidney failure.

]]>

Diet tips for diabetics with kidney disease
When diabetes leads to kidney disease the goal is to preserve kidney function as long as possible and manage diabetes. What you eat can affect both your blood sugar and your kidney function. A dietitian will work with you to create an eating plan that's right for you, probably using some of the diet tips presented here.

]]>

Introduction

Definition, causes and symptoms
All about diabetes Definition, causes and symptoms What is diabetes? Diabetes is a disease that affects your body?s ability to produce or use insulin. Insulin is a hormone. When your body turns the food you eat into energy (also called sugar or glucose), insulin is released to help transport this energy to th

]]>

Controlling diabetes
Diabetes is the leading cause of chronic kidney disease in the United States. By controlling diabetes through lifestyle choices such as diet and exercise, taking prescribed medicines and seeing a doctor regularly, people with diabetes can usually maintain a healthy lifestyle and help prevent chronic kidney disease and kidney failure. Find out what you can do to control diabetes.

]]>

Diabetes and chronic kidney disease
Diabetes and chronic kidney disease

Diabetes is the leading cause of chronic kidney disease in America. Many people with diabetes are not aware that chronic kidney disease can lead to kidney failure. However, having diabetes does not necessarily mean you will have kidney failure. Learn about the diabetes and kidney disease connection and how you can keep your kidneys healthy.

]]>

Preventing diabetic kidney disease
All about diabetes Preventing diabetic kidney disease How can I slow the progression of kidney disease? Keeping healthy is the most important part of delaying kidney disease. If you have diabetes and have been diagnosed with an early stage of chronic kidney disease, following your doctor?s instructions regard

]]>

Get the facts

Are you in control of your diabetes?
If you have diabetes, your doctor advises you to keep your glucose levels in a healthy range. One of the problems that can occur for diabetics who don’t control their diabetes is the risk of kidney disease which may lead to kidney failure and dialysis. Diabetes is the leading cause of kidney disease in America. Learn how you can control your diabetes to avoid other health complications such as renal disease.

]]>

Diabetic nephropathy
Image: Diabetic nephropathy

Diabetic nephropathy means kidney damage that occurs as a result of diabetes. Researchers believe poor control of blood sugar or blood glucose levels is one of the reasons people with diabetes develop this type of kidney disease. Learn about diabetic nephropathy symptoms, diagnosis and treatment.

 

 

]]>

Diabetes and peritoneal dialysis
diabetes and pd 340x160Diabetes mellitus is the number one cause of kidney failure in the United States, leading many people to need dialysis. Learn about the relationship between diabetes and chronic kidney disease (CKD), as well as how people with diabetes can choose to do the home dialysis treatment, peritoneal dialysis (PD).

]]>

diabetes and pd

diabetes and pd 340x160



that specifies the number of meals you should eat each day and when to eat them. The principle behind such a plan is the diabetic food pyramid, that breaks down the type of foods you can eat and the portions sizes you should consume.

By eating a balanced diet at regular intervals you control the peaks and troughs of your blood sugar level. This is good for the long term diabetic complications because bad blood sugar control over an extended period can lead to a number of cardiovascular problems, not least, heart disease.

A good diet and exercise can also help you to lose weight. If this is an issue for you, it will make your worse and may lead to insulin replacement therapy. It is thought that excess weight make it harder for the natural insulin produced in the body to work effectively.

Blood circulation is also affected by and this can lead to eye problems over time. The typical complication is known as diabetic retinopathy. Diabetic retinopathy can lead to blood flowing into the aqueous humor and interfering with the sight to a detached retina. Part of ongoing treatment is a regular examination every six months. This should include an eye exam.

Diabetic neuropathy is another complication that is caused by poor circulation. This generally manifest in the extremities of the body - like the feet and hands. Because blood does not flow to these parts of the body as it should, they tend to be more susceptible to cuts and bruises. They also take more time to heal because the healing properties in the blood are not available. This often results in poor hands, and particularly feet. It is important to pay careful attention to the condition of the feet. Wash and dry them thoroughly each day and trim off any calluses, corns or long nails. Monitor any cuts and bruises and treat with medication if the cut is not healing. Wear diabetic socks and shoes if your feet are especially sensitive.

Diabetes complications can be serious but they can also be minimized by proper eating habits, regular exercise and careful monitoring of the body and any changes.

For more on eating the right foods for type 2 check out diabeticdietsplan.com/ . The site has features on the diabetic food pyramid and planning a diabetic diet. Adrian writes about treating naturally.




Here are some more diabetes articles...

Some Facts Concerning Diabetes Treatment
By Groshan Fabiola
Diabetes treatment should place a healthy diet and exercise as a priority. Alternative medicine can be also useful.It is known that controlling the blood sugar is an important thing to do. With Read more...
Isalean ™ Shake 14 Meals Canister - A Perfect Meal Alternative
By Marcela De Vivo
With Isagenix IsaLean ™ Shake, you can shake up your meal alternative. In fact, it is the perfect meal alternative. It is the just right meal replacement that is particularly designed to replenish Read more...

Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes
<b>Condition</b>:   Type 1 Diabetes Mellitus<br/><b>Interventions</b>:   Behavioral: Diabetes related psychological counseling and education;   Device: Continuous Glucose Monitor<br/><b>Sponsors</b>:   University Hospital Case Medical Center;   National Institute of Mental Health (NIMH)<br/><b>Not yet recruiting</b> - verified March 2010
To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: AZD1656;   Drug: Gemfibrozil;   Drug: Placebo<br/><b>Sponsor</b>:   AstraZeneca<br/><b>Not yet recruiting</b> - verified March 2010
Effects of Caloric Restriction Alone Versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients With Diabetes Mellitus
<b>Conditions</b>:   Obesity;   Bariatric Surgery;   Morbid Obesity;   Diabetes Mellitus Type 2;   Diet Therapy<br/><b>Interventions</b>:   Procedure: Roux-en-Y Gastric Bypass;   Behavioral: Caloric Restriction<br/><b>Sponsor</b>:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified February 2010
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: AZD1656;   Drug: Pioglitazone<br/><b>Sponsor</b>:   AstraZeneca<br/><b>Recruiting</b> - verified March 2010
The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Canagliflozin 100 mg;   Drug: Placebo/sitagliptin 2x50 mg;   Drug: Canagliflozin 300 mg<br/><b>Sponsor</b>:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.<br/><b>Recruiting</b> - verified March 2010
Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: INSULIN GLARGINE;   Drug: INSULIN GLULISINE<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Recruiting</b> - verified March 2010
Comparing Google With A Focused Diabetes Search Engine
<b>Condition</b>:   Diabetes<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Beth Israel Deaconess Medical Center<br/><b>Recruiting</b> - verified March 2010
Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetic Vascular Complications<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Winthrop University Hospital<br/><b>Recruiting</b> - verified March 2010
Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine;   Drug: NN1250;   Drug: insulin aspart<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Recruiting</b> - verified March 2010
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
<b>Conditions</b>:   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetic Polyneuropathy<br/><b>Interventions</b>:   Drug: SB-509;   Other: Saline<br/><b>Sponsors</b>:   Sangamo Biosciences;   Juvenile Diabetes Research Foundation<br/><b>Recruiting</b> - verified March 2010
Corneal Endothelial Changes Associated With Phacoemulsification in Diabetes Mellitus Type II
<b>Conditions</b>:   Diabetes;   Cataract<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Frederiksberg University Hospital<br/><b>Completed</b> - verified August 2009
Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Abbott<br/><b>Completed</b> - verified March 2010
Intraarterial Infusion of Autologous Mesenchymal Stem Cells From Adipose Tissue in Diabetic Patients With Chronic Critical Limb Ischemia
<b>Conditions</b>:   Diabetes;   Limb Ischemia<br/><b>Interventions</b>:   Other: Autologous mesenchymal stem cells from adipose tissue.;   Other: Autologous mesenchymal stem cells from adipose tissue.;   Other: Autologous mesenchymal stem cells from adipose tissue.<br/><b>Sponsors</b>:   Fundacion Progreso y Salud, Spain;   Carlos III Health Institute<br/><b>Recruiting</b> - verified January 2010
Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects
<b>Conditions</b>:   Genotype;   Pharmacokinetic<br/><b>Intervention</b>:   Drug: Glipizide<br/><b>Sponsors</b>:   Chinese Academy of Sciences;   The First Affiliated Hospital of Lanzhou University<br/><b>Completed</b> - verified November 2009
Adolescent Cooking and Eating Study
<b>Condition</b>:   Polycystic Ovary Syndrome<br/><b>Intervention</b>:   Behavioral: Nutrition Education, Dietary Counseling, and Cooking<br/><b>Sponsors</b>:   Children's Hospital Boston;   Thrasher Research Fund<br/><b>Not yet recruiting</b> - verified March 2010
Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet
<b>Conditions</b>:   Diabetes Mellitus 1 or 2;   Midfoot Charcot Neuroarthropathy<br/><b>Interventions</b>:   Procedure: Surgery with Midfoot Fusion Bolt;   Procedure: Cast treatment<br/><b>Sponsor</b>:   AO Clinical Investigation and Documentation<br/><b>Not yet recruiting</b> - verified March 2010
An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Intervention</b>:   Drug: repaglinide<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified February 2010
Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment.
<b>Condition</b>:   Diabetes Type 2<br/><b>Interventions</b>:   Drug: Insulin-Levemir;   Drug: Exenatide-Bayetta;   Drug: Insulin-Levemir and Exenatide-Bayetta;   Device: SenseWear Pro3® armband;   Device: DexCom CGM<br/><b>Sponsors</b>:   Novo Nordisk;   BodyMedia<br/><b>Recruiting</b> - verified June 2009
Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 Diabetes
<b>Condition</b>:   Type II Diabetes Mellitus<br/><b>Intervention</b>:   Other: Spice polyphenols<br/><b>Sponsor</b>:   University of California, Los Angeles<br/><b>Recruiting</b> - verified February 2010
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Recruiting</b> - verified March 2010
A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents
<b>Condition</b>:   Type 2 Diabetes<br/><b>Interventions</b>:   Drug: exenatide;   Drug: Other antidiabetic therapies;   Other: No diabetes therapy<br/><b>Sponsors</b>:   Amylin Pharmaceuticals, Inc.;   Eli Lilly and Company<br/><b>Completed</b> - verified February 2010
Ranibizumab for Edema of the mAcula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
<b>Condition</b>:   Diabetic Macular Edema<br/><b>Interventions</b>:   Drug: Ranibizumab;   Drug: ranibizumab<br/><b>Sponsors</b>:   Johns Hopkins University;   Juvenile Diabetes Research Foundation<br/><b>Recruiting</b> - verified February 2010
BASAAL PLUS - Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Insulin glulisine;   Drug: Insulin glargine;   Drug: Premixed insulin (Insulin Aspart 30/70 )<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Recruiting</b> - verified March 2010
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
<b>Conditions</b>:   Schizophrenia;   Schizoaffective Disorders;   Schizophreniform Disorders<br/><b>Interventions</b>:   Drug: Pravastatin;   Drug: Placebo<br/><b>Sponsors</b>:   Massachusetts General Hospital;   Stanley Medical Research Institute<br/><b>Not yet recruiting</b> - verified March 2010
The Impact of a Video Cell Phone Reminder System on Glycemic Control in Patients With Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus<br/><b>Interventions</b>:   Device: cell phone delivered tele-educational;   Device: cell phone<br/><b>Sponsors</b>:   Walter Reed Army Medical Center;   Affinity Networks Inc.<br/><b>Active, not recruiting</b> - verified June 2009
DETECT-Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment
<b>Condition</b>:   Cardiovascular Diseases<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Dresden University of Technology;   Johann Wolfgang Goethe University Hospitals;   Max-Planck-Institute of Psychiatry;   University of Magdeburg;   Medical University of Graz;   Universitätsklinikum Hamburg-Eppendorf<br/><b>Completed</b> - verified February 2010
Cohort Study in Type 2 Diabetes in China
<b>Condition</b>:   Type 2 Diabetes<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   China Cardiometabolic Registries;   Roche Pharma AG;   VitalStrategic Research Institute;   Chinese College of Cardiovascular Physicians;   China Endocrinologist Association<br/><b>Not yet recruiting</b> - verified February 2010
Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: NN1250;   Drug: NN1250<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Recruiting</b> - verified February 2010
A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: sitagliptin phosphate;   Drug: Comparator: placebo to pioglitazone;   Drug: Comparator: placebo to sitagliptin;   Drug: Comparator: pioglitazone;   Drug: Comparator: glimepiride or gliclazide;   Drug: Comparator: metformin;   Drug: Comparator: pioglitazone rescue therapy<br/><b>Sponsor</b>:   Merck<br/><b>Not yet recruiting</b> - verified February 2010
Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: sitagliptin phosphate (+) metformin hydrochloride;   Drug: Comparator: metformin;   Drug: Comparator: sitagliptin;   Drug: Comparator: Placebo<br/><b>Sponsor</b>:   Merck<br/><b>Not yet recruiting</b> - verified February 2010
Navigator 1.5 Accuracy Study
<b>Condition</b>:   Diabetes Mellitus<br/><b>Intervention</b>:   Device: FreeStyle Navigator Continuous Glucose Monitoring System Version 1.5<br/><b>Sponsor</b>:   Abbott Diabetes Care<br/><b>Completed</b> - verified February 2010
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Abbott;   McKesson Canada<br/><b>Recruiting</b> - verified February 2010
Pilot Pharmacokinetic Study of Daily Versus Monthly High-Dose Cholecalciferol Supplementation
<b>Condition</b>:   Healthy Volunteers<br/><b>Interventions</b>:   Dietary Supplement: Single High Dose Cholecalciferol;   Dietary Supplement: Daily Dose Cholecalciferol<br/><b>Sponsor</b>:   Mayo Clinic<br/><b>Recruiting</b> - verified March 2010
Effects of N-acetylcysteine on Diabetic Foot Oxygenation
<b>Condition</b>:   Foot Ulcer, Diabetic<br/><b>Intervention</b>:   Drug: N-acetylcysteine<br/><b>Sponsor</b>:   University of Turin, Italy<br/><b>Completed</b> - verified February 2010
Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines
<b>Condition</b>:   Polyneuropathy<br/><b>Intervention</b>:   Drug: Cilostazol<br/><b>Sponsor</b>:   Otsuka Pharmaceutical, Inc., Philippines<br/><b>Completed</b> - verified February 2010
Self Management and Reminders With Technology: SMART Appraisal of an Integrated Personal Health Record (PHR)
<b>Condition</b>:   Cardiovascular Risk<br/><b>Interventions</b>:   Other: SMART PHR;   Other: usual care<br/><b>Sponsors</b>:   University of Pittsburgh;   Agency for Healthcare Research and Quality (AHRQ)<br/><b>Not yet recruiting</b> - verified March 2010
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use NSAIDs and/or Colchicines.
<b>Condition</b>:   Acute Gout<br/><b>Interventions</b>:   Drug: ACZ885;   Drug: Triamcinolone acetonide<br/><b>Sponsor</b>:   Novartis Pharmaceuticals<br/><b>Not yet recruiting</b> - verified March 2010
A Trial of Telmisartan Prevention of Cardiovascular Disease
<b>Condition</b>:   Hypertension<br/><b>Interventions</b>:   Drug: Non-ARB (standard therapy);   Drug: ARB (Telmisartan)<br/><b>Sponsor</b>:   Kumamoto University<br/><b>Recruiting</b> - verified June 2009
Documentation of Humira in Psoriasis Patients in Routine Clinical Practice
<b>Condition</b>:   Moderate to Severe Plaque Psoriasis<br/><b>Intervention</b>:   Biological: adalimumab (Humira)<br/><b>Sponsor</b>:   Abbott<br/><b>Recruiting</b> - verified February 2010
Healthy Homes/Healthy Kids Preschool
<b>Condition</b>:   Obesity<br/><b>Interventions</b>:   Behavioral: Busy Bodies/Better Bites;   Behavioral: Healthy Spots/Safe Tots<br/><b>Sponsors</b>:   HealthPartners Research Foundation;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Not yet recruiting</b> - verified March 2010
Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices
<b>Condition</b>:   Esophageal Varices<br/><b>Intervention</b>:   Device: Capsule endoscopy, Esophagogastroduodenoscopy<br/><b>Sponsors</b>:   University of California, Los Angeles;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Completed</b> - verified June 2008
Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding
<b>Condition</b>:   Colitis, Ischemic<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   University of California, Los Angeles;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Completed</b> - verified December 2009